We are live on ! Find out more
RENE

Cartesian Growth Corp II

Delisted

RENE was delisted on the 12th of May, 2025.

0 hedge funds and large institutions have $0 invested in Cartesian Growth Corp II in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 10 (-1)

100% less capital invested

Capital invested by funds: $1.71M → $0 (-$1.71M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
Holders Change
-1
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CA
Crossingbridge Advisors
New York
-$1.71M
Name Holding Trade Value Shares
Change
Change in
Stake
CA
1
Crossingbridge Advisors
New York
-$1.71M -140,587 Closed

RENE Hedge Fund Activity: Q4 2025 in Review

0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Cartesian Growth Corp II (RENE) for Q4 2025, worth a combined $0 — down 100% from $1.71M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of RENE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Crossingbridge Advisors, exiting entirely with an estimated $1.71M sold.

  • 0 institutional investors held Cartesian Growth Corp II (RENE) as of Q4 2025, down from 1 in Q3 2025.
  • Funds reported $0 of Cartesian Growth Corp II stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Cartesian Growth Corp II positions in Q4 2025 and 1 closed out, a net change of -1 holder.
  • The largest Cartesian Growth Corp II seller in Q4 2025 was Crossingbridge Advisors, an estimated $1.71M sold.

Based on aggregated 13F filings for Q4 2025.